🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation

RecruitingPhase 3Ages 18 Years - anyAllUniversity of Alabama at Birmingham
NCT03912194 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Smoking remains the single most preventable cause of morbidity and mortality in the United States, accounting for approximately half a million deaths every year. The current study will investigate the efficacy and mechanisms of change of a novel smoking cessation intervention. The current study will thus provide essential information regarding a treatment that has the potential to enhance the efficacy of existing smoking cessation interventions, thereby having a beneficial impact on the public health of the United States.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * at least 18 years of age * smoke at least 5 cigarettes per day * Expired breath carbon monoxide (CO) reading of at least five parts per million * report the intention to quit * reside in the Birmingham area with no plan to relocate outside of the area in the next 6 months * access to a telephone Exclusion Criteria: * inability to speak English * presence of a condition that contraindicates use of the nicotine patch * presence of conditions that might interfere with compliance with the protocol or greatly complicate treatment * any acutely life-threatening disease * concurrent participation in a formal treatment program for smoking cessation * current use of any pharmacotherapy for smoking cessation
💊

What it tests

  • cognitive-behavioral withdrawal regulation strategies
  • relaxation strategies
  • early withdrawal exposure
📍

Where

1 site
Ryals Public Health Building
Birmingham, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy